Pharmgate’s parent company launches successful IPO in China
August 10, 2012 – Jinhe Biotechnology, parent of Pharmgate LLC, successfully completed an initial public offering of 27.23 million A shares of common stock at
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.